FeOx/NC纳米酶清除ROS保护软骨细胞的作用研究

The protective effects of FeOx/NC nanozymes on chondrocytes by scavenging reactive oxygen species

  • 摘要:
    目的 探讨铁氧化物(FeOx/NC)纳米酶对大鼠骨关节炎(OA)的软骨保护作用及其机制。
    方法 合成并表征FeOx/NC纳米酶,检测其模拟超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和谷胱甘肽过氧化物酶(GPx)活性的能力。体外提取SD大鼠软骨细胞,设正常对照组、H2O2组、NC+H2O2组及FeOx/NC+H2O2组,采用CCK-8法和Calcein-AM/PI染色评估生物相容性,ROS探针检测其清除ROS能力。利用实时荧光定量PCR(RT-qPCR)、免疫荧光和蛋白免疫印迹法(western blotting)检测MMP-13和IL-6的基因与蛋白表达。将20只大鼠随机分为假手术组、生理盐水组、NC组和FeOx/NC组,除假手术组外,其余3组通过前交叉韧带横断术构建OA模型,观察关节大体形态,并通过HE染色与番红O—固绿染色评估组织病理变化。
    结果 TEM结果证实FeOx/NC纳米酶成功合成,具备类SOD、CAT和GPx活性。CCK-8与Calcein-AM/PI染色实验表明其对软骨细胞无明显毒性。ROS探针检测结果显示,FeOx/NC+H2O2组的荧光强度明显低于H2O2组(P<0.000 1)。RT-qPCR结果显示,与H2O2组相比,FeOx/NC+ H2O2MMP13IL-6基因表达水平降低(P<0.001或P<0.000 1)。免疫荧光结果显示,FeOx/NC+ H2O2组MMP-13荧光强度显著低于H2O2组(P<0.000 1)。western blotting结果显示,与H2O2组相比,FeOx/NC+ H2O2组MMP-13和IL-6蛋白表达水平显著降低(P<0.000 1)。大体观察和组织学染色结果显示,相比于生理盐水组,FeOx/NC组的关节软骨组织损伤有所减轻。
    结论 FeOx/NC纳米酶具有出色的生物相容性和多酶催化活性,能够清除软骨细胞内的ROS,抑制氧化应激,缓解OA的进展。

     

    Abstract:
    Objective To investigate the chondroprotective effects and underlying mechanisms of iron oxidebased nanozymes (FeOx/NC) in a rat model of osteoarthritis (OA).
    Methods FeOx/NC nanozymes were synthesized and characterized, and their enzyme-mimetic activities resembling superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were detected. Primary chondrocytes were isolated in vitro from SD rats and divided into four groups: control group, H2O2 group, NC+H2O2 group, and FeOx/NC+H2O2 group. The biocompatibility was assessed using the cell counting kit-8 (CCK-8) assay and Calcein-AM/PI staining, and reactive oxygen species (ROS)-scavenging ability was examined with ROS probes. Gene and protein expression levels of MMP-13 and IL-6 were measured via reverse transcription-quantitative polymerase chain reaction (RTqPCR), immunofluorescence, and western blotting. Twenty rats were randomly assigned to four groups: sham group, saline group, NC group, and FeOx/NC group. Except for the sham group, OA models were established by anterior cruciate ligament transection. Joint morphology was observed, and histopathological changes were evaluated by hematoxylin-eosin (HE) and Safranin O-Fast Green staining.
    Results TEM analysis confirmed the successful synthesis of FeOx/NC, which exhibited SOD-, CAT-, and GPx-like activities. CCK-8 and Calcein-AM/PI assays demonstrated that FeOx/NC exhibited no significant cytotoxicity towards chondrocytes. The ROS probe analysis revealed significantly reduced fluorescence intensity in the FeOx/NC+H2O2 group compared with the H 2O2 group (P < 0.05). RT-qPCR results showed that the mRNA expression levels of MMP-13 and IL-6 in the FeO x/NC+H2O2 group were significantly lower than those in the H2O2 group (P < 0.05). The results of immunofluorescence showed the fluorescence intensity of MMP-13 in the FeOx/NC+H2O2 group was significantly lower than that in the H 2O2 group (P < 0.05). Western blotting demonstrated that the protein expression levels of MMP- 13 and IL-6 were significantly decreased in the FeOx/NC+H2O2 group compared with the H2O2 group (P < 0.05). Macroscopic and histological evaluations demonstrated that FeOx/NC treatment alleviated cartilage damage compared with the saline group.
    Conclusion FeOx/NC nanozymes exhibit excellent biocompatibility and possess multi-enzyme catalytic activity, enabling them to efficiently scavenge intracellular ROS in chondrocytes, thereby suppressing oxidative stress and alleviating the progression of OA.

     

/

返回文章
返回